Akrotome Imaging, Inc. is focused on the clinical translation of core research into new approaches to clinical practice and standards of care, which reduce costs, enhance quality of life for patients, and improve outcomes. Akrotome's technology portfolio of protease-binding, quenched, near-infrared (NIRF) probes supports a wide range of clinical applications from guided cancer surgery to therapeutic monitoring, companion diagnostics, and management of inflammatory disease.
